T cell vaccination (TCV) is proven to be an effective means of regulating autoreactive T cells through regulatory network of CD8+ and CD4+ T cell subsets. Both regulatory T cell (Treg) subsets are thought to contribute to suppression of circulating myelin basic protein (MBP)-reactive T cells and some clinical improvement seen in clinical trials in multiple sclerosis (MS). CD8+ T cells induced by TCV belong to cytotoxic anti-idiotypic T cell subset interacting with the T cell receptors of MBP-reactive T cells. In contrast, the nature of CD4+ Treg subset is poorly understood. They exhibit unique regulatory properties through the production of IL-10 but not Th1 cytokines, resulting in a potent inhibitory effect on MBP-reactive T cells. Their reactivity and inhibition appear restricted to activated T cells, regardless of antigen specificity, but not resting cells. Further evidence suggests that CD4+ Treg cells induced by TCV react with and are activated by endogenously processed IL-2 receptor alpha chain (IL-2Ra). These findings have begun to unfold the unique properties and functional role of CD4+ Treg induced by TCV in the regulation of autoreactive T cells in humans. In this study, we propose to investigate the central hypothesis that TCV induces the activation and in vivo expansion of CD4+ Treg cells through interaction with IL-2Ra expressed on activated autoreactive T cells and that IL-2Ra has an anti-inflammatory property by inducing a CD4+ Treg response. The study has three specific aims.
In Aim 1, the role of TCV in in vivo expansion of pre-existing CD4+ Treg pool will be determined by examining the precursor frequency of CD4+ Treg cells in peripheral blood mononuclear cells (PBMC) derived from MS patients before and after TCV. The results will be analyzed to correlate with serum cytokines, the frequency of MBP-reactive T cells and other parameters in the same patients. Cloned CD4+ Treg cell lines will be characterized in detail to address their functional role and heterogeneity, reactivity and MHC restriction, mode of induction and interaction with various target T cells.
Aim 2 will focus on the reactivity pattern and interaction of CD4+ Treg cells with IL-2Ra using well-characterized T cell lines in two experimental systems by testing the reactivity of CD4+ Treg T cell lines to endogenously processed IL-2Ra using autologous B cell transfectants and to soluble IL-2Rot using recombinant protein in functional assays. Additional experiments will delineate the region(s) of IL-2Ra preferably recognized by CD4+ Treg using target cells transfected with truncated gene segments and overlapping peptides.
In Aim 3, we will define the potency and specificity of IL-2Rc_ protein as a specific agent for the direct induction of CD4+ Treg cell response in PBMC as well as the role of TCV in this process by analyzing the T cell responses, as the frequency of reactive CD4+ Treg cells, to IL-2R(x protein or preferably recognized peptides in pre- and postvaccination PBMC and those of controls. Parallel experiments are designed to evaluate the inhibitory effect of IL-2Ra on MBP-reactive T cell responses through its intrinsic property of inducing CD4+ Treg cell response in MBP-primed PBMC cultures. The overall results will provide new insights into the role of IL- 2Ro_ in regulation of pro-inflammatory T cell response in autoimmune conditions. ? ?

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Utz, Ursula
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
Schools of Medicine
United States
Zip Code
Hong, Jian; Li, Haiyan; Chen, Meiyue et al. (2009) Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis. Int Immunol 21:1329-40
Wang, Zhaojun; Hong, Jian; Sun, Wei et al. (2006) Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 116:2434-41
Hong, Jian; Zang, Ying C Q; Nie, Hong et al. (2006) CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis. Proc Natl Acad Sci U S A 103:5024-9
Hong, Jian; Li, Ningli; Zhang, Xuejun et al. (2005) Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A 102:6449-54
Singh, Rana A K; Zhang, Jingwu Z (2004) Differential activation of ERK, p38, and JNK required for Th1 and Th2 deviation in myelin-reactive T cells induced by altered peptide ligand. J Immunol 173:7299-307